Review



12-gene assay endopredict® ep  (Sividon Diagnostics GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sividon Diagnostics GmbH 12-gene assay endopredict® ep
    12 Gene Assay Endopredict® Ep, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/12+gene+risk+score+endopredict/pm36976899-76-0-5
    Average 90 stars, based on 1 article reviews
    12-gene assay endopredict® ep - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Biomarker Discovery:

    Article Title: Developing a new generation of breast cancer clinical gene expression tests
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [ ], a second-generation multigene test trained to predict distant recurrence in ER + /HER2 − tumors, and by extension the need for adjuvant chemotherapy. ..

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER/HER2 tumors, and by extension the need for adjuvant chemotherapy. ..

    Adjuvant:

    Article Title: Developing a new generation of breast cancer clinical gene expression tests
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [ ], a second-generation multigene test trained to predict distant recurrence in ER + /HER2 − tumors, and by extension the need for adjuvant chemotherapy. ..

    Article Title: Developing a new generation of breast cancer clinical gene expression tests.
    Article Snippet: .. In the previous issue, Martin and colleagues describe the third clinical validation of EndoPredict (EP; Sividon Diagnostics GmbH, Cologne, Germany) [1], a secondgeneration multigene test trained to predict distant recurrence in ER/HER2 tumors, and by extension the need for adjuvant chemotherapy. ..



    Similar Products

    endopredict ep  (Myriad Genetics)
    90
    Myriad Genetics endopredict ep
    Endopredict Ep, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/endopredict+ep/pm40644891-340-0-2
    Average 90 stars, based on 1 article reviews
    endopredict ep - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    endopredict® (ep)  (Myriad Genetics)
    90
    Myriad Genetics endopredict® (ep)
    Endopredict® (Ep), supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/endopredict+ep/pm38587783-23-0-2
    Average 90 stars, based on 1 article reviews
    endopredict® (ep) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    endopredict (ep)/epclin  (Myriad Genetics)
    90
    Myriad Genetics endopredict (ep)/epclin
    Predictive gene tests used in breast cancer care.
    Endopredict (Ep)/Epclin, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/endopredict/pmc10608445-37-0-3
    Average 90 stars, based on 1 article reviews
    endopredict (ep)/epclin - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    12-gene assay endopredict® ep  (Sividon Diagnostics GmbH)
    90
    Sividon Diagnostics GmbH 12-gene assay endopredict® ep
    Predictive gene tests used in breast cancer care.
    12 Gene Assay Endopredict® Ep, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/12+gene+risk+score+endopredict/pm36976899-76-0-5
    Average 90 stars, based on 1 article reviews
    12-gene assay endopredict® ep - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    endopredict® (12-ep)  (Sividon Diagnostics GmbH)
    90
    Sividon Diagnostics GmbH endopredict® (12-ep)
    Predictive gene tests used in breast cancer care.
    Endopredict® (12 Ep), supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/endopredict+++12+ep+/pmc09486269-4-0-12
    Average 90 stars, based on 1 article reviews
    endopredict® (12-ep) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    endopredict (ep)  (Myriad Genetics)
    90
    Myriad Genetics endopredict (ep)
    Commercially available multiparameter gene expression assays.
    Endopredict (Ep), supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/endopredict+(ep)/endopredict+ep/pmc08366126-57-45-47
    Average 90 stars, based on 1 article reviews
    endopredict (ep) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Predictive gene tests used in breast cancer care.

    Journal: Journal of Personalized Medicine

    Article Title: The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer

    doi: 10.3390/jpm13101476

    Figure Lengend Snippet: Predictive gene tests used in breast cancer care.

    Article Snippet: EndoPredict (EP)/EPclin , Myriad Genetics , 12 , RT-qPCR , RNA from FFPE tumour tissue , Postmenopausal women with early HR+/HER2 breast cancer who have been on ET for 5 years , Yes (1–3 positive nodes) , EP score , EP score of 0 to <5 low risk, EP 5 to 15 high risk; EPclin < 3.3 low risk, EPclin ≥ 3.3 high risk , Benefit from adjuvant chemotherapy , Risk of distant and late recurrence after 10 and 15 years.

    Techniques: Adjuvant, Microarray, Immunohistochemistry

    Commercially available multiparameter gene expression assays.

    Journal: Therapeutic Advances in Medical Oncology

    Article Title: The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes

    doi: 10.1177/17588359211038467

    Figure Lengend Snippet: Commercially available multiparameter gene expression assays.

    Article Snippet: This review will summarize the clinical utility of several commonly used multiparameter gene expression assays , including the Oncotype DX Recurrence Score (RS) (Genomic Health, Exact Sciences, Madison WI), MammaPrint (Agendia, Inc., Irvine, CA), PAM50 Risk of Recurrence (ROR) score (Prosigna, Veracyte, San Francisco, CA), EndoPredict (EP) (Myriad Genetics, Salt Lake City, UT), and Breast Cancer Index (BCI) (Biotheranostics, Inc., San Diego, CA), in early hormone receptor-positive (HR+) HER2 negative BCA.

    Techniques: Gene Expression

    Selected clinical trials evaluating gene expression assays.

    Journal: Therapeutic Advances in Medical Oncology

    Article Title: The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes

    doi: 10.1177/17588359211038467

    Figure Lengend Snippet: Selected clinical trials evaluating gene expression assays.

    Article Snippet: This review will summarize the clinical utility of several commonly used multiparameter gene expression assays , including the Oncotype DX Recurrence Score (RS) (Genomic Health, Exact Sciences, Madison WI), MammaPrint (Agendia, Inc., Irvine, CA), PAM50 Risk of Recurrence (ROR) score (Prosigna, Veracyte, San Francisco, CA), EndoPredict (EP) (Myriad Genetics, Salt Lake City, UT), and Breast Cancer Index (BCI) (Biotheranostics, Inc., San Diego, CA), in early hormone receptor-positive (HR+) HER2 negative BCA.

    Techniques: Clinical Proteomics, Gene Expression, Adjuvant, Comparison

    Clinical practice guidelines for use of gene expression assays to guide adjuvant chemotherapy recommendations.

    Journal: Therapeutic Advances in Medical Oncology

    Article Title: The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes

    doi: 10.1177/17588359211038467

    Figure Lengend Snippet: Clinical practice guidelines for use of gene expression assays to guide adjuvant chemotherapy recommendations.

    Article Snippet: This review will summarize the clinical utility of several commonly used multiparameter gene expression assays , including the Oncotype DX Recurrence Score (RS) (Genomic Health, Exact Sciences, Madison WI), MammaPrint (Agendia, Inc., Irvine, CA), PAM50 Risk of Recurrence (ROR) score (Prosigna, Veracyte, San Francisco, CA), EndoPredict (EP) (Myriad Genetics, Salt Lake City, UT), and Breast Cancer Index (BCI) (Biotheranostics, Inc., San Diego, CA), in early hormone receptor-positive (HR+) HER2 negative BCA.

    Techniques: Gene Expression, Adjuvant